Jennye Laws-Woolf
December 11, 2020

Paul Grof, MD, PhD

12:00 noon CDT | via Zoom Webinar


"Lithium and Bipolar Illness: The risky business of short-selling gold-standard, evidence-based treatment"

 

Summary:

In all 30+ guidelines for bipolar disorder treatment, lithium is placed as number one, the treatment of choice. So why is it prescribed less and less everywhere? We offer an explanation based on three significant misunderstandings about lithium treatment. These three issues are confusing clinical practice. 

 

CME credit for Psychiatry Grand Rounds is only available during the live feed time and for a brief time immediately following. The code for this week's session is displayed at the opening and closing of the meeting and also in the Chair's Office Zoom Account Name during the meeting.

 

AMA PRA Category 1 Credit™(1.00)  
CE (APA) (1.00) | Attendance (1.00)

 

The recorded webinar can be viewed at the link below:

  Dec 11 Psychiatry Grand Rounds | Grof

 

This talk is sponsored by the

Orr Lecture Fund

Department of Psychiatry and Behavioral Sciences
This educational activity received no commercial support.

 

Grand Rounds Enrichment Discussion

For a deeper understanding of the topic ahead of Dr. Grof's talk, please join Dr. Reid Finlayson on Wednesday December 9 on Zoom as he delves a little deeper into the subject matter. The discussion for this week centers around the Vanderbilt Medicine article featuring Dr. Finlayson's story which can be found here:

 One Psychiatrist’s Journey

by Kelsey Herbers